<?xml version="1.0" encoding="UTF-8"?>
<p id="para0007">In light of increasing numbers of cases of COVID-19 locally and internationally 
 <xref rid="bib0002" ref-type="bibr">[2]</xref>, SGH faced competing manpower needs arising from health crisis management, leading to uncertainty over manpower allocation of non-direct patient care personnel (e.g. antibiotic stewardship practitioners). This article aims to describe the impact of COVID-19 on antibiotic use and the role of an antibiotic stewardship programme (ASP) at SGH, an 1800-bed, tertiary care hospital. The multi-disciplinary ASP comprises nine trained infectious diseases (ID) pharmacists and three ID physicians. The pharmacy team performs daily electronic audits of selected broad-spectrum antibiotic prescriptions (carbapenems, piperacillin-tazobactam, ciprofloxacin and levofloxacin) for appropriateness in terms of indication, route, duration and choice, and intervenes where appropriate. The audited prescriptions of more complex cases are reviewed daily with the attending ID physician who is rostered for the day 
 <xref rid="bib0003" ref-type="bibr">[3]</xref>.
</p>
